Recently, the molecular markers of CD34 and BRAF mutation are interestingly found to be associated with brain tumors with epilepsy, especially with epilepsy-associated GG (Blümcke et al., 1999; Deb et al., 2006; Schindler et al., 2011; Giulioni et al., 2019; Xing et al., 2021). Here, CD34 is linked to brain neoplasm.